(April 2024)
MHQP and the Massachusetts Sickle Cell Association (MSCA) have joined forces again to identify new research directions aimed at improving pain crisis care for people with sickle cell disease (SCD), a life-threatening, inherited blood disease. This project builds on a prior collaboration between the two organizations focused on SCD
(February 2024)
Black and Asian patients reported worse experiences in primary care than White patients across many categories in MHQP’s 2023 statewide Patient Experience Survey, the results of which were released today. The same was true of Hispanic/Latino patients when compared to non-Hispanic/Latino patients.
Evidence has shown that positive patient experiences are associated with better health
(February 2024)
MHQP is honored to announce that we have received a grant from the Robert Wood Johnson Foundation’s Evidence for Action program, in partnership with the Cambridge Health Alliance Health Equity Research Lab. This project will facilitate an exploration of social risk factors in adjustment models,
(January 2024)
2023 was an eventful year for MHQP, a year in which we continued expanding beyond our historical focus on measuring patient experience and took important steps to help strengthen primary care and advance health equity in Massachusetts. These efforts culminated in the launch of two major initiatives — the
(January 2024)
MHQP is pleased to announce that, in partnership with the Endometriosis Association, we have received a funding award through the Eugene Washington PCORI Engagement Award Program, an initiative of the Patient-Centered Outcomes Research Institute, to identify new research directions to reduce disparities in endometriosis care for Black women, as
(September 2023)
We can no longer ignore the systemic racial and ethnic disparities in patient experiences that plague our healthcare system. Organizations across the state are taking action to address these disparities, but these complex issues can only be effectively addressed by working collaboratively across organizational lines, not in organizational siloes. At the Health Equity Trends Summit assembled by
(September 2023)
It’s a valued resource for some, but not known by many ― MHQP’s Clinical Guidelines. Since 2001, MHQP has been helping to ensure all patients receive the same high standard of care through the annual publication of consistent, evidence-based, best practices guidelines for Adult Preventive Care, Pediatric Preventive Care
(May 2023)
In the summer of 2022, MHQP partnered with the Massachusetts Sickle Cell Association (MSCA) to lead a set of convenings to explore new directions for research into patient-centered approaches to help people with sickle cell disease (SCD) self-manage their pain. This effort was made possible through an award from
(April 2023)
“Patients may be more likely to develop type 2 diabetes if they are Black, Alaska Native, American Indian, Asian, Native Hawaiian, Pacific Islander, or Hispanic/Latino.”
This was one of the “Risk Factors for Type 2 Diabetes” identified in the Diabetes section of last year’s version of MHQP’s Clinical Guidelines. MHQP
(March 2023)
Through a Special Initiatives grant from the Blue Cross Blue Shield of Massachusetts Foundation (BCBSMAF), MHQP has launched a new project designed to help better understand why Asian patients report worse experiences with primary care than other racial populations. A deeper understanding requires a more nuanced consideration of the
